Supporting GSM’s continued international expansion and further development of its integrated online platform and curriculum ...

MSD and Daiichi Sankyo have announced first subject dosing in the randomised IDeate-Prostate01 Phase III trial of ifinatamab ...

Abbott and MSD Pharmaceuticals have partnered to distribute oral anti-diabetic medicines in India. Abbott will distribute MSD ...

Abbott and MSD announce partnership to distribute sitagliptin brands in India, aiming to strengthen reach in ₹950-1,000 crore ...

Abbott and MSD Pharmaceuticals partner to distribute oral anti-diabetic medicines in India, benefiting millions with Type 2 ...

MSD has received US Food and Drug Administration (FDA) approval for its anti-programmed death receptor-1 (PD-1) therapy, ...

A stunning century on a dry Headingley track, that propelled India to 471 in the first innings, once again erupted the ...

MSD has begun the randomised MOBILIZE-1 Phase III trial to assess the investigational quadrivalent vaccine, V181.

Rishabh Pant impressed with a mature yet explosive century at Headingley, blending flair with control to become India's top Test wicketkeeper-batter.

Sitagliptin has played a crucial role in managing type 2 diabetes by lowering HbA1c levels and improving blood sugar control.

Jasprit Bumrah finished with 3/48 on Saturday in Leeds, while the remaining Indian bowlers went wicketless for 154 runs.

Under the terms of the partnership, Abbott will utilise its distribution infrastructure to promote MSD’s sitagliptin-based ...